Gilder Gagnon Howe & Co’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,527
| Closed | -$934K | – | 268 |
|
|
2023
Q4 | $934K | Sell |
7,527
-1
| -0% | -$124 | 0.01% | 206 |
|
|
2023
Q3 | $873K | Buy |
7,528
+25
| +0.3% | +$2.9K | 0.01% | 213 |
|
|
2023
Q2 | $881K | Buy |
7,503
+1,876
| +33% | +$220K | 0.01% | 231 |
|
|
2023
Q1 | $450K | Buy |
+5,627
| New | +$450K | 0.01% | 224 |
|
|
2021
Q2 | – | Sell |
-6,769
| Closed | -$521K | – | 429 |
|
|
2021
Q1 | $521K | Sell |
6,769
-14
| -0.2% | -$1.08K | ﹤0.01% | 316 |
|
|
2020
Q4 | $407K | Sell |
6,783
-363
| -5% | -$21.8K | ﹤0.01% | 288 |
|
|
2020
Q3 | $308K | Sell |
7,146
-275
| -4% | -$11.9K | ﹤0.01% | 291 |
|
|
2020
Q2 | $307K | Buy |
7,421
+7,384
| +19,957% | +$305K | ﹤0.01% | 264 |
|
|
2020
Q1 | $2K | Buy |
37
+15
| +68% | +$811 | ﹤0.01% | 275 |
|
|
2019
Q4 | $1K | Hold |
22
| – | – | ﹤0.01% | 286 |
|
|
2019
Q3 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 283 |
|